Parameter | RA patients (n = 120) | Healthy controls (n = 130) | P value |
---|---|---|---|
Sex | Â | Â | 0.13 |
 Male, n (%) | 12 (10%) | 22 (17%) |  |
 Female, n (%) | 108 (90%) | 108 (83%) |  |
Age (years) | 38.25 ± 10.13 | 39.9 ± 15.2 | 0.32 |
Range | (19–60) | (20–59) |  |
Hemoglobin (g/dl) | 11.83 ± 1.63 | 12.3 ± 2.5 | 0.08 |
Total leukocyte count (× 103/mm3) | 7.72 ± 2.48 | 8 ± 3.1 | 0.43 |
Platelet count (×103/mm3) | 279.6 ± 80.85 | 288.26 ± 75.2 | 0.4 |
ALT (U/l) | 25.63 ± 10.89 | 27.51 ± 11.48 | 0.19 |
Creatinine (mg/dl) | 0.82 ± 0.22 | 0.9 ± 0.42 | 0.06 |
Disease duration (y) | 6.22 ± 4.45 | NA |  |
MS (min) | 25.38 ± 25.18 | NA |  |
ESR (mm) | 39.13 ± 23.6 | NA |  |
RF, n (%) | Â | NA | Â |
 Positive | 90 (75) |  |  |
 Negative | 30 (25) |  |  |
ANA, n (%) | Â | NA | Â |
 Positive | 18 (15) |  |  |
 Negative | 102 (85) |  |  |
DAS28-CRP | 2.98 ± 1.73 | NA |  |
Remission < 2.3 | 48 (40) |  |  |
Low disease activity 2.3–2.7 | 9 (7.5) |  |  |
Mild disease activity 2.7–4.1 | 30 (25) |  |  |
High disease activity > 4.1 | 33 (27.5) |  |  |
VAS (mm) | 5.22 ± 3.34 | NA |  |
Swollen joint count (SJC) | 5.33 ± 5.66 | NA |  |
Tender joint count (TJC) | 5.17 ± 5.45 | NA |  |
Arthritis, n (%) | Â | NA | Â |
 Severe | 87 (72.5) |  |  |
 Mild | 33 (27.5) |  |  |
Deformities, n (%) | Â | NA | Â |
 Yes | 84 (70) |  |  |
 No | 36 (30) |  |  |
Fever, n (%) | |||
 Yes | 15 (12.5) |  |  |
 No | 105 (87.5) | NA |  |
Subcutaneous nodules, n (%) | |||
 Yes | 30 (25) |  |  |
 No | 90 (75) |  |  |
Extra articular manifestations, n (%) | Â | NA | Â |
 Yes | 24 (20) |  |  |
 No | 96 (80) |  |  |
Treatment | NA | Â | Â |
Steroids only | 6 (5) | Â | Â |
MTX only | 60 (50) | Â | Â |
HQN only | 6 (5) | Â | Â |
MTX + HQN | 24 (20) |  |  |
MTX + steroids | 24 (20) |  |  |